Isoxicam

Isoxicam

Clinical data
Trade names	Maxicam
Identifiers
CAS Number	34552-84-6
ATC code	M01AC03 (WHO) (withdrawn)
PubChem	CID 47206482
DrugBank	DB08942
ChemSpider	10442695
UNII	8XU734C4NG
KEGG	D04639
ChEBI	CHEBI:CHEBI:76163
Chemical data
Formula	C14H13N3O5S
Molar mass	335.34 g/mol
SMILES CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O

Isoxicam is a nonsteroidal anti-inflammatory drug (NSAID) that was taken or applied to reduce inflammation and as an analgesic reducing pain in certain conditions. The drug was introduced in 1983 for the treatment of rheumatic disorders. In 1985 it was withdrawn from the French market, due to an association with serious adverse effects, including death. The drug was subsequently withdrawn worldwide.^[1][2]

References

1. Consolidated List of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by Governments, United Nations, 2003, p. 123 link to 2005 ed
2. Fung, M.; Thornton, A.; Mybeck, K.; Wu, J. H.-h.; Hornbuckle, K.; Muniz, E. (1 January 2001). "Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999". Therapeutic Innovation & Regulatory Science 35 (1): 293–317. doi:10.1177/009286150103500134.